EMR.AXEMR.AXASX
Loading
EBITDA Over TimeExpanding
Percentile Rank100
3Y CAGR+21.8%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
+21.8%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
1.8x
Solid growth
Streak
4 yr
Consecutive growthExpanding
PeriodValueYoY Change
2025$200.48M+11.8%
2024$179.39M+30.2%
2023$137.76M+24.2%
2022$110.90M+769.8%
2021$-16.56M-52.8%
2020$-10.83M-23.2%
2019$-8.79M+22.5%
2018$-11.34M-32.5%
2017$-8.56M-537.7%
2016$-1.34M-